InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Krishnan Rajesh, 首席技术官. Director active across 1 company, notably Oncternal Therapeutics, Inc.. Aggregated, 5 filings have been published. Activity tracked since 3 January 2022. The latest transaction was filed on 3 January 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Krishnan Rajesh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
11,838 股@ US$0.496136.0% 占其流量Common StockSEC:0001209191-24-000974:0
10,897 股@ US$0.3624.1% 占其流量Common StockSEC:0001209191-23-041312:0
6,238 股@ US$1.0239.9% 占其流量Common StockSEC:0001209191-23-002035:0
43,125 股0Common StockSEC:0001209191-22-043737:0
29,867 股0Common StockSEC:0001209191-22-001976:0
5 条申报中的 5 条
About Krishnan Rajesh
Rajesh Krishnan is Chief Technology Officer at Oncternal Therapeutics, Inc. He is responsible for the technical direction of the company, overseeing the development of new technologies and products. His expertise is essential for innovation and the success of Oncternal Therapeutics.
